Second Genome
Corey Goodman is a scientist, educator, and entrepreneur. Dr. Goodman is currently a Managing Partner of venBio Partners LLC, a venture capital firm focused on innovative therapeutics for major unmet medical needs. Dr. Goodman is Chair of the board of two biotechnology companies (Second Genome and Alexo), and a member of the board of two others (Checkmate and NFlection). He chaired another company (Labrys) until its acquisition by Teva.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Second Genome
1 followers
Second Genome is a clinical stage company with a mission to improve human health by unlocking the full potential of the microbiome